qPCR verified the expression changes of GO and KEGG pathway enriched sarcopenia related DEGs. حسب Wenbin Wu (292223)

الموضوعات:

Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs. حسب Wenbin Wu (292223)

الموضوعات:

Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

الموضوعات:

The linearly decreasing convergence factor a. حسب Junhao Wei (6816803)

Enrichment analysis of genes from the significant MS module. حسب Lai Jiang (2401513)

الموضوعات:

A total of 700 DEGs. حسب Wei He (131453)

"…Compared with normal tissues, AAD tissues exhibited a significant decrease in CD8 T cells and an increase in NK cells and macrophages.…"

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…"

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…"

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…"

Overview of the WeARTolerance program. حسب Ana Beato (20489933)

الموضوعات:

Study selection criteria. حسب Filip Stanicic (17808254)

الموضوعات:

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

الموضوعات:

PRISMA flow chart. حسب Filip Stanicic (17808254)

الموضوعات:

Differentially expressed genes (DEGs) exhibiting both increased and decreased expression levels. حسب Liwen Wang (276995)

Bluetooth beacons with colour coded lanyards. حسب J Mark Ansermino (13958512)

الموضوعات:

Brain regions with significantly decreased activations for the Raven task are shown in blue. حسب Morteza Fattahi (15892028)

All DEGs in wild-type and <i>atb’’αβγδ</i> plants. حسب Hyuk Sung Yoon (20208672)

"…Transcriptome analysis showed a significant decrease in the expression of <i>CYP707A3</i>, a gene potentially targeted by VIP1 that regulates abscisic acid (ABA) catabolism, in the <i>atb’’αβγδ</i> mutant compared to wild type leaves. …"

KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia. حسب Wenbin Wu (292223)

الموضوعات:

Top 10 significant functional annotations of up-regulated DEGs. حسب Meitner Cadena (22216261)

"…Functional annotations are ordered by decreasing significance, with color indicating significance according to the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.…"

Top 10 significant functional annotations of down-regulated DEGs. حسب Meitner Cadena (22216261)

"…Functional annotations are ordered by decreasing significance, with color indicating significance level based on the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.…"